- Home
- EHC vs PCVX Comparison
EHC vs PCVX Comparison
Compare EHC & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EHC
- PCVX
- Stock Information
- Founded
- EHC 1983
- PCVX 2013
- Country
- EHC United States
- PCVX United States
- Employees
- EHC N/A
- PCVX N/A
- Industry
- EHC Hospital/Nursing Management
- PCVX Biotechnology: Pharmaceutical Preparations
- Sector
- EHC Health Care
- PCVX Health Care
- Exchange
- EHC Nasdaq
- PCVX Nasdaq
- Market Cap
- EHC 12.4B
- PCVX 4.0B
- IPO Year
- EHC 1986
- PCVX 2020
- Fundamental
- Price
- EHC $124.37
- PCVX $42.47
- Analyst Decision
- EHC Strong Buy
- PCVX Strong Buy
- Analyst Count
- EHC 8
- PCVX 8
- Target Price
- EHC $140.63
- PCVX $114.17
- AVG Volume (30 Days)
- EHC 585.6K
- PCVX 2.0M
- Earning Date
- EHC 10-29-2025
- PCVX 11-04-2025
- Dividend Yield
- EHC 0.61%
- PCVX N/A
- EPS Growth
- EHC 30.39
- PCVX N/A
- EPS
- EHC 5.11
- PCVX N/A
- Revenue
- EHC $5,669,100,000.00
- PCVX N/A
- Revenue This Year
- EHC $11.57
- PCVX N/A
- Revenue Next Year
- EHC $8.79
- PCVX N/A
- P/E Ratio
- EHC $24.30
- PCVX N/A
- Revenue Growth
- EHC 11.80
- PCVX N/A
- 52 Week Low
- EHC $87.85
- PCVX $27.66
- 52 Week High
- EHC $127.86
- PCVX $118.54
- Technical
- Relative Strength Index (RSI)
- EHC 53.64
- PCVX 64.05
- Support Level
- EHC $122.11
- PCVX $42.75
- Resistance Level
- EHC $124.14
- PCVX $45.12
- Average True Range (ATR)
- EHC 2.15
- PCVX 2.14
- MACD
- EHC -0.29
- PCVX 0.22
- Stochastic Oscillator
- EHC 72.98
- PCVX 74.41
About EHC Encompass Health Corporation
Encompass Health Corp provides post-acute healthcare services in the United States through a network of inpatient rehabilitation hospitals. Inpatient rehabilitation contributes the majority of the firm's revenue and provides specialized rehabilitative treatment through a network of inpatient hospitals. These hospitals are concentrated in the eastern half of the United States and Texas.
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.